Annovis Bio, Inc. SEC filings ANVS
Annovis Bio, Inc. has 312 filings in SEC EDGAR's recent list, going back to Jan 15, 2010. Its latest annual report, Form 10-K, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Nov 4, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Nov 4, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Oct 30, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Other events
|
Oct 20, 2026 | Oct 19, 2026 |
| DEFA14A | Additional proxy material | Oct 7, 2026 | — |
| DEF 14A | Proxy statement | Sep 11, 2026 | Oct 14, 2026 |
| PRE 14A | Preliminary proxy statement | Aug 25, 2026 | Aug 24, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Other events
|
Jul 10, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 20, 2026 | May 20, 2026 |
| 424B5 | Prospectus supplement | May 20, 2026 | — |
| 424B5 | Prospectus supplement | May 19, 2026 | — |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 10, 2026 | Apr 9, 2026 |
| 424B5 | Prospectus supplement | Apr 9, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2026 | Mar 16, 2026 |
| 10-K | Annual report | Mar 13, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 12, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 28, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 28, 2025 | Oct 26, 2025 |
| 424B5 | Prospectus supplement | Oct 28, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Oct 14, 2025 | Oct 10, 2025 |
| 424B5 | Prospectus supplement | Oct 14, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2025 | Sep 25, 2025 |
| CORRESP | Letter to the SEC | Sep 29, 2025 | — |
| CORRESP | Letter to the SEC | Sep 19, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 4, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Aug 15, 2025 | Aug 11, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 20, 2025 | Jun 19, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
May 13, 2025 | May 9, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | May 1, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | May 1, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Listing notice, Officer or director change, Regulation FD disclosure
|
Mar 27, 2025 | Mar 26, 2025 |
| 10-K | Annual report | Mar 21, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2025 | Mar 21, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 5, 2025 | Feb 5, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 5, 2025 | Feb 3, 2025 |
| 424B5 | Prospectus supplement | Feb 4, 2025 | — |
| 424B5 | Prospectus supplement | Feb 3, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 11, 2024 | Dec 11, 2024 |
| 8-K |
Current report
Material agreement
|
Dec 11, 2024 | Dec 11, 2024 |
| 424B5 | Prospectus supplement | Dec 11, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Dec 9, 2024 | Dec 4, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Oct 15, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2024 | Aug 15, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 16, 2024 | Jul 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 10, 2024 | Jul 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 2, 2024 | Jul 2, 2024 |
| S-8 | Employee stock plan registration | Jun 21, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 11, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 5, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 21, 2024 | May 21, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 9, 2024 | May 9, 2024 |
| DEFA14A | Additional proxy material | May 6, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 6, 2024 | May 6, 2024 |
| 8-K |
Current report
Other events
|
May 2, 2024 | May 2, 2024 |
| 8-K |
Current report
Officer or director change
|
May 1, 2024 | May 1, 2024 |
| 424B5 | Prospectus supplement | May 1, 2024 | — |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Material agreement
|
Apr 26, 2024 | Apr 25, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 3, 2024 | Apr 2, 2024 |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Mar 22, 2024 | Mar 22, 2024 |
| 424B5 | Prospectus supplement | Mar 22, 2024 | — |
| 8-K |
Current report
Material agreement
|
Mar 21, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 20, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Other events
|
Mar 20, 2024 | Mar 19, 2024 |
| 424B5 | Prospectus supplement | Mar 19, 2024 | — |
| 424B5 | Prospectus supplement | Mar 19, 2024 | — |
| 8-K |
Current report
Material agreement
|
Mar 15, 2024 | Mar 15, 2024 |
| EFFECT | Filing | Feb 12, 2024 | — |
| S-3/A | Filing | Feb 12, 2024 | — |
| CORRESP | Letter to the SEC | Feb 9, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2024 | — |
| S-3 | Shelf registration | Feb 1, 2024 | — |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Nov 1, 2023 | Oct 30, 2023 |
| 424B5 | Prospectus supplement | Nov 1, 2023 | — |
| 424B5 | Prospectus supplement | Oct 30, 2023 | — |
| 8-K |
Current report
Other events
|
Oct 30, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Other events
|
Oct 13, 2023 | Oct 10, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 16, 2023 | Jun 16, 2023 |
| DEFA14A | Additional proxy material | Jun 2, 2023 | — |
| 8-K |
Current report
Auditor change
|
May 30, 2023 | May 30, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 15, 2023 |
| D | Filing | Apr 25, 2023 | — |
| PRE 14A | Preliminary proxy statement | Apr 17, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Agreement ended, Other events
|
Apr 4, 2023 | Apr 4, 2023 |
| 8-K |
Current report
Material agreement
|
Apr 3, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
Apr 3, 2023 | Apr 3, 2023 |
| 424B5 | Prospectus supplement | Mar 31, 2023 | — |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 31, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Restatement
|
Mar 6, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Other events
|
Feb 13, 2023 | Feb 13, 2023 |
| 8-K |
Current report
Other events
|
Jan 6, 2023 | Jan 6, 2023 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 12, 2022 | Sep 9, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 30, 2022 | Aug 29, 2022 |
| 10-Q | Quarterly report | Aug 8, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2022 | Jun 2, 2022 |
| 10-Q | Quarterly report | May 4, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| DEFA14A | Additional proxy material | Apr 18, 2022 | — |
| DEF 14A | Proxy statement | Apr 18, 2022 | Jun 2, 2022 |
| 10-K | Annual report | Mar 2, 2022 | Dec 31, 2021 |
| 25 | Filing | Nov 26, 2021 | — |
| CERT | Nyse certification | Nov 17, 2021 | — |
| 8-A12B | Filing | Nov 17, 2021 | — |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2021 | Nov 12, 2021 |
| 10-Q | Quarterly report | Nov 3, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 5, 2021 | Oct 5, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 11, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 29, 2021 | Jul 28, 2021 |
| 10-Q | Quarterly report | Jul 28, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2021 | Jun 1, 2021 |
| 424B4 | Prospectus | May 24, 2021 | — |
| 8-K |
Current report
Material agreement, Other events
|
May 24, 2021 | May 21, 2021 |
| FWP | Free writing prospectus | May 21, 2021 | — |
| 424B4 | Prospectus | May 21, 2021 | — |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| DEFA14A | Additional proxy material | Apr 19, 2021 | — |
| DEF 14A | Proxy statement | Apr 19, 2021 | Jun 1, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2021 | Apr 9, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 23, 2021 | Mar 23, 2021 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Mar 15, 2021 | Mar 14, 2021 |
| 10-K | Annual report | Mar 3, 2021 | Dec 31, 2020 |
| EFFECT | Filing | Feb 11, 2021 | — |
| CORRESP | Letter to the SEC | Feb 9, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2021 | — |
| S-3 | Shelf registration | Feb 1, 2021 | — |
| 10-Q | Quarterly report | Nov 4, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Jul 29, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 9, 2020 | Jun 9, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2020 | Jun 3, 2020 |
| DEFA14A | Additional proxy material | Jun 1, 2020 | — |
| 10-Q | Quarterly report | May 5, 2020 | Mar 31, 2020 |
| DEF 14A | Proxy statement | Apr 24, 2020 | Jun 3, 2020 |
| 8-K |
Current report
Other events
|
Apr 3, 2020 | Apr 3, 2020 |
| 10-K | Annual report | Mar 25, 2020 | Dec 31, 2019 |
| S-8 | Employee stock plan registration | Feb 14, 2020 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 6, 2020 | Jan 30, 2020 |
| 424B4 | Prospectus | Jan 30, 2020 | — |
| S-1MEF | Filing | Jan 29, 2020 | — |
| EFFECT | Filing | Jan 28, 2020 | — |
| CERT | Nyse american certification | Jan 28, 2020 | — |
| 8-A12B | Form 8-a12b | Jan 28, 2020 | — |
| CORRESP | Letter to the SEC | Jan 24, 2020 | — |
| CORRESP | Letter to the SEC | Jan 24, 2020 | — |
| S-1/A | Amended registration statement | Jan 24, 2020 | — |
| S-1/A | Amended registration statement | Jan 21, 2020 | — |
| FWP | Free writing prospectus | Dec 10, 2019 | — |
| S-1/A | Amended registration statement | Nov 19, 2019 | — |
| CORRESP | Letter to the SEC | Sep 20, 2019 | — |
| S-1/A | Amended registration statement | Sep 20, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2019 | — |
| S-1/A | Amended registration statement | Aug 28, 2019 | — |
| CORRESP | Letter to the SEC | Aug 27, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2019 | — |
| S-1/A | Amended registration statement | Aug 8, 2019 | — |
| CORRESP | Letter to the SEC | Aug 8, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2019 | — |
| S-1 | Registration statement | Jul 3, 2019 | — |
| CORRESP | Letter to the SEC | Jul 2, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 21, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2019 | — |
| DRSLTR | Filing | May 24, 2019 | — |
| DRS/A | Filing | May 24, 2019 | — |
| DRSLTR | Filing | May 15, 2019 | — |
| DRS | Filing | May 15, 2019 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANVS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Malvern, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1477845
- Former names
- QR Pharma, Inc. (until Mar 15, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.